B-cell maturation antigen

Tumor necrosis factor receptor superfamily, member 17

PDB rendering based on 1oqd.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols TNFRSF17 ; BCM; BCMA; CD269; TNFRSF13A
External IDs OMIM: 109545 MGI: 1343050 HomoloGene: 920 GeneCards: TNFRSF17 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 608 21935
Ensembl ENSG00000048462 ENSMUSG00000022496
UniProt Q02223 O88472
RefSeq (mRNA) NM_001192 NM_011608
RefSeq (protein) NP_001183 NP_035738
Location (UCSC) Chr 16:
11.97 – 11.97 Mb
Chr 16:
11.31 – 11.32 Mb
PubMed search
BCMA TALL-1 binding domain

crystal structure of stall-1 and bcma
Identifiers
Symbol BCMA-Tall_bind
Pfam PF09257
InterPro IPR015337
SCOP 1oqd
SUPERFAMILY 1oqd

B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene.

TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF).[1][2][3]

Function

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.[3]

Interactions

TNFRSF17 has been shown to interact with the B-cell activating factor TNFSF13B.[4][5] A conserved domain at the N-terminus, BCMA TALL-1 binding domain, is required for binding to the TNFSF13B.[4]

Diseases

TNFRSF17 is implicated in leukemia, lymphomas, and multiple myeloma [6] (see the "Mitelman Database" [7] and the Atlas of Genetics and Cytogenetics in Oncology and Haematology,[8]).

References

  1. Laâbi Y, Gras MP, Carbonnel F, Brouet JC, Berger R, Larsen CJ, Tsapis A (Nov 1992). "A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma". The EMBO Journal 11 (11): 3897–904. PMC 556899. PMID 1396583.
  2. Laabi Y, Gras MP, Brouet JC, Berger R, Larsen CJ, Tsapis A (Apr 1994). "The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed". Nucleic Acids Research 22 (7): 1147–54. doi:10.1093/nar/22.7.1147. PMC 523635. PMID 8165126.
  3. 1 2 "Entrez Gene: TNFRSF17 tumor necrosis factor receptor superfamily, member 17".
  4. 1 2 Liu Y, Hong X, Kappler J, Jiang L, Zhang R, Xu L, Pan CH, Martin WE, Murphy RC, Shu HB, Dai S, Zhang G (May 2003). "Ligand-receptor binding revealed by the TNF family member TALL-1". Nature 423 (6935): 49–56. doi:10.1038/nature01543. PMID 12721620.
  5. Shu HB, Johnson H (Aug 2000). "B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1". Proceedings of the National Academy of Sciences of the United States of America 97 (16): 9156–61. doi:10.1073/pnas.160213497. PMC 16838. PMID 10908663.
  6. http://atlasgeneticsoncology.org/Genes/TNFRSF17ID42616ch16p13.html
  7. "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer".
  8. "Atlas of Genetics and Cytogenetics in Oncology and Haematology". atlasgeneticsoncology.org.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article incorporates text from the public domain Pfam and InterPro IPR015337


This article is issued from Wikipedia - version of the Monday, October 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.